Biological preparation method of (3R, 5R)-6-cyano-3,5-dyhydroxytert-butylhexanoate

A technology of tert-butyl hydroxycaproate and tert-butyl hexanoate, applied in the field of biopharmaceuticals, can solve the problems of complicated operation steps and high cost, and achieve the effects of simplifying operation steps, reducing production process and low raw material price
CN103695486AInactive Publication Date: 2014-04-02HUANGGANG HUAYANG PHARMA +1

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
HUANGGANG HUAYANG PHARMA
Publication Date
2014-04-02
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
Patent Text Reader

Abstract

The embodiment of the invention provides a biological preparation method of (3R, 5R)-6-cyano-3,5-dyhydroxytert-butylhexanoate and belongs to the field of biological pharmacy. The preparation method comprises the following steps: by taking (5R)-6-chloro-5-hydroxy-3-tert-butyloxohexanoate as a raw material in a triethanolamine hydrochloride buffer solution, maintaining the pH value to be 6-8 under the actions of a complex enzyme of recombinant ketoreductase and glucose dehydrogenase, dehalogenase, a cofactor and glucose by using a cyaniding reagent, and reacting to obtain the (3R, 5R)-6-cyano-3,5-dyhydroxytert-butylhexanoate at room temperature. According to the preparation method provided in the invention, the (5R)-6-chloro-5-hydroxy-3-tert-butyloxohexanoate is taken as the raw material, a reduction reaction and a cyano substitution reaction are finished to obtain the product through a one-pot method under the catalysis of the complex enzyme of recombinant ketoreductase and glucose dehydrogenase and the dehalogenase, and the method is simple in process and low in production cost.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of biopharmaceuticals, and in particular relates to a biological preparation method of atorvastatin intermediate (3R,5R)-6-cyano-3,5-dihydroxyhexanoic acid tert-butyl ester. Background technique

[0002] Statins reduce low-density lipoprotein cholesterol (LDL-C) levels by inhibiting HMG-CoA reductase in the cholesterol synthesis pathway, and have a good effect on hyperlipidemia mainly caused by elevated cholesterol. Widely used lipid-regulating drugs. Atorvastatin (Atorvastatin) has become a new third-generation, fully synthetic, highly purified, and highly selective HMG-CoA reductase inhibitor due to its advantages of rapid onset of action, strong lipid-lowering effect, and long action time. The most promising statin drugs in the market. And (3R,5R)-6-cyano-3,5-dihydroxyhexanoic acid tert-butyl ester is the most important intermediate of atorvastatin, therefore, the development of (3R,5R)-6-cyano-3 , The synthetic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More